Innovative Industrial Properties Inc

This management proposal asks stockholders to approve the Company’s 2026 Omnibus Incentive Plan, which would replace the 2016 plan and authorize a reserve of up to 1,250,000 shares (subject to adjustments for awards granted under the prior plan between April 10, 2026 and the effective date). Management seeks approval to ensure it can continue granting equity and cash incentive awards (restricted stock, RSUs, performance awards, options, SARs and cash incentives) to attract and retain employees, directors and consultants and to align their interests with long-term stockholder value. The filing frames the requested share pool as modest (projected fully-diluted overhang of ~5.3%) and necessary to continue granting awards at recent historical rates for approximately five years, while noting potential variability depending on grant mix and stock price. Key plan features include broad Administrator discretion, various award types (including performance-based awards), anti-repricing protections, limits on awards to non-employee directors, clawback and transfer restrictions, and standard adjustment provisions for corporate events and change-of-control scenarios. The Board recommends a FOR vote, arguing equity is a critical retention and alignment tool and that failing approval would force reliance on cash-based alternatives that could impair alignment and cash management. From a governance perspective, the proposal is typical for a growing REIT but requires scrutiny of share reserve size, dilution assumptions, performance-measure design, and the Administrator’s discretionary authorities. Analysts should evaluate historical burn rate (three-year average 0.4%), current outstanding award run-rate, the company’s capital needs and the company’s stated intent to replace the 2016 plan (which otherwise would leave insufficient shares for future grants). Given the company’s recent investments and strategic diversification into life sciences, management argues the plan supports talent retention needed to execute that strategy while maintaining safeguards (e.g., repricing prohibition and clawback).

This non-binding management proposal asks stockholders to approve, on an advisory basis, the Company’s 2025 executive compensation as disclosed in the Compensation Discussion & Analysis and accompanying tables. Management frames its program as pay-for-performance with ~78% of CEO and ~80% of other NEOs’ target direct compensation at-risk, a mix of annual cash incentives tied 50% to formulaic metrics (AFFO per diluted share, investments, AFFO payout ratio) and 50% to individual/strategic goals, and multi-year restricted stock/RSU awards that vest over three years. The Board points to recent financial results, capital actions (revolving credit, preferred ATM, repurchases), and strategic investments (including an investment in IQHQ and diversification into life sciences) as context for compensation decisions. Opponents could point to lower say-on-pay support in 2024–2025 (~73–74% support) and forfeited PSUs in prior cycles as concerns about alignment and performance-based design; management has moved to more formulaic annual incentives and adopted stock ownership guidelines in response. The vote is advisory, so outcomes guide but do not bind the Board; a negative vote would typically trigger enhanced shareholder engagement and potential design changes. Analysts should assess the rigor of performance metrics, the balance of discretionary vs. objective components, historical payouts vs. targets, and whether compensation changes implemented after prior stockholder feedback adequately address concerns. The Board recommends voting FOR, arguing that the current structure better aligns executive incentives with stockholder interests while recognizing industry-specific risks in the regulated cannabis sector that informed compensation design.

This management-sponsored, non-binding proposal asks stockholders to indicate whether they prefer the frequency of future advisory votes on executive compensation to occur every one, two, or three years. The Board recommends an annual (one-year) frequency, arguing that yearly advisory votes provide more timely stockholder feedback on compensation practices and allow the Company to respond more frequently to investor concerns. The proxy explains that the option receiving the highest number of votes will be considered the stockholders’ recommendation, but the Board retains discretion and will consider the vote when determining future practice. From a governance perspective, an annual vote tends to increase board accountability and engagement with investors, while multi-year votes are sometimes preferred by companies seeking predictable governance cycles; shareholders typically favor annual votes for responsiveness. Analysts evaluating this item should consider prior engagement outcomes, the company’s responsiveness to say-on-pay results, and whether annual feedback is likely to materially affect compensation policy given the company’s recent adjustments to incentive plan design and stockholder outreach. The Board’s recommendation for 'ONE YEAR' aligns with current practice and recent changes intended to enhance pay-for-performance alignment.